The biotech sector was having some trouble settling on a direction earlier in today's trading session, but lately the measures that track the group were firmly in positive territory.

The American Stock Exchange Biotech Index was recently up 3%. The Dow Jones Biotech Index were gaining 1.2%, and the Biotech HOLDRs was also rising 1.2%. The latter two were down earlier in the session.

Applied Biosystems ( ABI), a part of Applera, posted earnings of 22 cents a share this morning, a penny below the Thomson Financial/First Call estimate, and 4 cents below last year's same-quarter comparison. Revenue rose 3.5% in the quarter, and the company said it expects a slowdown in capital purchases and currency effects to "restrain revenue growth for the next few quarters" traders seemed keen on the stock today. Shares of Applied Biosystems were climbing 7.5% to $27.42.

Celera Genomics ( CRA), the other company operating under the Applera umbrella, reported a wider-than-expected loss of 56 cents a share this morning. Analysts expected a loss of 54 cents a share. Celera, which is moving a large amount of its expenditures to drug discovery and research and away from online information, recently rose 7% to $31.20.

Amgen ( AMGN), which is posting earnings after the bell, fell 3.7% to $57 today. Chiron ( CHIR), which beat earnings estimates by a penny yesterday, also slipped, falling 0.2% to $42. Genome Therapeutics ( GENE) was climbing 0.7% to $12.45, and Genzyme General ( GENZ) rose 6.3% to $55.42. Shares of Biogen ( BGEN) were slipping 0.2% to $52.84.

More from Stocks

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

3 Warren Buffett Stock Picks That Could Be Perfect for Your Retirement Portfolio

3 Warren Buffett Stock Picks That Could Be Perfect for Your Retirement Portfolio

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites

Why Starbucks Latest Data Reveal Should Worry Investors

Why Starbucks Latest Data Reveal Should Worry Investors

Salesforce Is Hitting on All Cylinders as Shares Notch an All-Time High

Salesforce Is Hitting on All Cylinders as Shares Notch an All-Time High